Toggle navigation
Toggle navigation
Home
DCUM Forums
Nanny Forums
Events
About DCUM
Advertising
Search
Recent Topics
Hottest Topics
FAQs and Guidelines
Privacy Policy
Your current identity is: Anonymous
Login
Preview
Subject:
Forum Index
»
Health and Medicine
Reply to "Paxlovid"
Subject:
Emoticons
More smilies
Text Color:
Default
Dark Red
Red
Orange
Brown
Yellow
Green
Olive
Cyan
Blue
Dark Blue
Violet
White
Black
Font:
Very Small
Small
Normal
Big
Giant
Close Marks
[quote=Anonymous][quote=Anonymous]Your doctor is absolutely correct that [b]there are no studies that show any effect one way or the other for Paxlovid on long covid. [/b] Point for that doctor![/quote] Hmmm, not so much. [quote][b]Real-World Effectiveness of Nirmatrelvir in Protecting Long COVID for Outpatient Adult Patients – A Large-Scale Observational Cohort Study from the RECOVER Initiative[/b] https://pmc.ncbi.nlm.nih.gov/articles/PMC11213188/ ... [b]Paxlovid treatment was associated with a lower risk of incident Long COVID across systems as shown in Fig. 2D,[/b] including post-acute neurological conditions (sleep disorders, cognitive problems, headache, encephalopathy, dementia), post-acute pulmonary conditions (pulmonary fibrosis, acute pharyngitis, shortness of breath), post-acute blood conditions (anemia), post-acute metabolic conditions (edema, diabetes, malnutrition), post-acute digestive conditions (abdominal pain, constipation), post-acute musculoskeletal conditions (joint pain), and some general conditions in the post-acute phase (e.g., malaise and fatigue, fever, smell, and taste). ... [b]Paxlovid treatment was also associated with a lower risk of incident Long COVID in different subpopulations[/b] stratified by sex, race, age, baseline risk conditions (except for pregnant females), infection time, and different rural-urban commuting areas as shown in Fig. 3. [/quote] [quote][b]Paxlovid tied to fewer COVID-19 hospitalizations, reduced risk of long COVID[/b] https://www.cidrap.umn.edu/covid-19/paxlovid-tied-fewer-covid-19-hospitalizations-reduced-risk-long-covid A new retrospective cohort study conducted in Dubai shows that [b]the antiviral nirmatrelvir plus ritonavir, sold as Paxlovid, is tied to a 61% reduction in COVID-19 hospitalization and a 58% lower rate of long COVID.[/b] [/quote] UC Davis Health: [quote][b]Long COVID: What have we learned?[/b] https://health.ucdavis.edu/news/headlines/long-covid-what-have-we-learned/2024/10 Most importantly, we have learned that [b]both vaccination and treatment with Paxlovid reduces the likelihood of long COVID[/b].[/quote][/quote]
Options
Disable HTML in this message
Disable BB Code in this message
Disable smilies in this message
Review message
Search
Recent Topics
Hottest Topics